Trust Company of Vermont’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $40.9M | Buy |
+162,450
| New | +$35M | 1.52% | 15 |
|
|
2025
Q4 | $38.5M | Sell |
168,625
-5,899
| -3% | -$1.34M | 1.61% | 12 |
|
|
2025
Q3 | $40.4M | Buy |
174,524
+12,456
| +8% | +$2.54M | 1.76% | 10 |
|
|
2025
Q2 | $30.1M | Sell |
162,068
-728
| -0.4% | -$135K | 1.42% | 12 |
|
|
2025
Q1 | $34.1M | Sell |
162,796
-6,787
| -4% | -$1.32M | 1.7% | 9 |
|
|
2024
Q4 | $30.1M | Sell |
169,583
-2,907
| -2% | -$534K | 1.46% | 12 |
|
|
2024
Q3 | $34.1M | Buy |
172,490
+1,222
| +0.7% | +$228K | 1.71% | 9 |
|
|
2024
Q2 | $29.4M | Buy |
171,268
+7,483
| +5% | +$1.24M | 1.6% | 10 |
|
|
2024
Q1 | $29.8M | Buy |
163,785
+23,925
| +17% | +$4.12M | 1.66% | 8 |
|
|
2023
Q4 | $21.7M | Sell |
139,860
-19,306
| -12% | -$2.81M | 1.45% | 12 |
|
|
2023
Q3 | $23.7M | Buy |
159,166
+1,671
| +1% | +$245K | 1.6% | 10 |
|
|
2023
Q2 | $21.2M | Sell |
157,495
-2,532
| -2% | -$371K | 1.38% | 11 |
|
|
2023
Q1 | $25.5M | Sell |
160,027
-915
| -0.6% | -$140K | 1.78% | 6 |
|
|
2022
Q4 | $26M | Sell |
160,942
-3,293
| -2% | -$505K | 1.91% | 6 |
|
|
2022
Q3 | $22M | Sell |
164,235
-1,195
| -0.7% | -$171K | 1.74% | 8 |
|
|
2022
Q2 | $25.3M | Sell |
165,430
-3,252
| -2% | -$497K | 1.94% | 7 |
|
|
2022
Q1 | $27.3M | Sell |
168,682
-3,060
| -2% | -$444K | 1.85% | 6 |
|
|
2021
Q4 | $23.3M | Sell |
171,742
-851
| -0.5% | -$101K | 1.47% | 10 |
|
|
2021
Q3 | $18.6M | Buy |
172,593
+2,391
| +1% | +$273K | 1.32% | 15 |
|
|
2021
Q2 | $19.2M | Buy |
170,202
+2,917
| +2% | +$329K | 1.34% | 12 |
|
|
2021
Q1 | $18.1M | Buy |
167,285
+155
| +0.1% | +$16.6K | 1.36% | 15 |
|
|
2020
Q4 | $17.9M | Buy |
167,130
+4,202
| +3% | +$404K | 1.43% | 12 |
|
|
2020
Q3 | $14.3M | Sell |
162,928
-100
| -0.1% | -$9.41K | 1.31% | 17 |
|
|
2020
Q2 | $16M | Sell |
163,028
-35,749
| -18% | -$3.15M | 1.58% | 9 |
|
|
2020
Q1 | $15.1M | Buy |
198,777
+2,513
| +1% | +$214K | 1.42% | 13 |
|
|
2019
Q4 | $17.4M | Sell |
196,264
-497
| -0.3% | -$41.3K | 1.31% | 16 |
|
|
2019
Q3 | $14.9M | Sell |
196,761
-5,853
| -3% | -$401K | 1.2% | 19 |
|
|
2019
Q2 | $14.7M | Buy |
202,614
+277
| +0.1% | +$21.8K | 1.22% | 19 |
|
|
2019
Q1 | $16.3M | Sell |
202,337
-10,299
| -5% | -$843K | 1.4% | 12 |
|
|
2018
Q4 | $19.6M | Sell |
212,636
-2,231
| -1% | -$196K | 1.9% | 8 |
|
|
2018
Q3 | $20.3M | Sell |
214,867
-504
| -0.2% | -$47.8K | 1.72% | 10 |
|
|
2018
Q2 | $20M | Buy |
215,371
+1,449
| +0.7% | +$142K | 1.79% | 7 |
|
|
2018
Q1 | $20.2M | Sell |
213,922
-1,856
| -0.9% | -$204K | 1.91% | 6 |
|
|
2017
Q4 | $20.9M | Sell |
215,778
-425
| -0.2% | -$40.1K | 1.94% | 5 |
|
|
2017
Q3 | $19.2M | Sell |
216,203
-40
| -0% | -$3.04K | 1.91% | 5 |
|
|
2017
Q2 | $15.7M | Buy |
216,243
+3,617
| +2% | +$243K | 1.61% | 8 |
|
|
2017
Q1 | $13.9M | Buy |
212,626
+2,301
| +1% | +$145K | 1.5% | 12 |
|
|
2016
Q4 | $13.2M | Buy |
210,325
+10,214
| +5% | +$623K | 1.52% | 12 |
|
|
2016
Q3 | $12.6M | Buy |
200,111
+9,048
| +5% | +$586K | 1.58% | 11 |
|
|
2016
Q2 | $11.8M | Buy |
191,063
+13,278
| +7% | +$809K | 1.57% | 11 |
|
|
2016
Q1 | $10.2M | Buy |
177,785
+5,961
| +3% | +$332K | 1.42% | 14 |
|
|
2015
Q4 | $10.2M | Buy |
171,824
+2,521
| +1% | +$145K | 1.46% | 13 |
|
|
2015
Q3 | $9.21M | Buy |
169,303
+3,025
| +2% | +$197K | 1.43% | 14 |
|
|
2015
Q2 | $11.2M | Buy |
166,278
+3,236
| +2% | +$211K | 1.63% | 10 |
|
|
2015
Q1 | $9.54M | Buy |
163,042
+14,907
| +10% | +$901K | 1.39% | 14 |
|
|
2014
Q4 | $9.69M | Sell |
148,135
-270
| -0.2% | -$17K | 1.41% | 14 |
|
|
2014
Q3 | $8.57M | Buy |
148,405
+4,415
| +3% | +$245K | 1.3% | 20 |
|
|
2014
Q2 | $8.13M | Sell |
143,990
-686
| -0.5% | -$36K | 1.25% | 21 |
|
|
2014
Q1 | $7.44M | Buy |
144,676
+4,237
| +3% | +$214K | 1.22% | 21 |
|
|
2013
Q4 | $7.42M | Sell |
140,439
-768
| -0.5% | -$37.7K | 1.24% | 19 |
|
|
2013
Q3 | $6.32M | Buy |
141,207
+3,597
| +3% | +$159K | 1.16% | 21 |
|
|
2013
Q2 | $5.69M | Buy |
+137,610
| New | +$6.02M | 1.11% | 21 |
|
Other funds holding ABBV
Trust Company of Vermont's ABBV Position: Q2 2026 in Review
Trust Company of Vermont opened a new position in AbbVie (ABBV) in Q2 2026: 162,450 shares worth $40.9M. The stake represents 1.52% of the portfolio and ranks #15 among its holdings. This is a return to the name: Trust Company of Vermont previously reported a position in ABBV as recently as Q4 2025.
Trust Company of Vermont first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 2,794 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Trust Company of Vermont held 162,450 shares of AbbVie worth $40.9M as of Q2 2026.
- AbbVie was a new Trust Company of Vermont position in Q2 2026.
- AbbVie made up 1.52% of Trust Company of Vermont's portfolio in Q2 2026, its #15 holding.
- Trust Company of Vermont first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 2,794 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Trust Company of Vermont's 13F filing for Q2 2026, filed 7 Aug 2026.